These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 30898756)

  • 1. Neutrophil/Lymphocyte Ratio Is an Independent Prognostic Factor in Elderly Patients with High-Grade Gliomas.
    Gan Y; Zhou X; Niu X; Li J; Wang T; Zhang H; Yang Y; Liu Y; Mao Q
    World Neurosurg; 2019 Jul; 127():e261-e267. PubMed ID: 30898756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Cumulative Score Based on Preoperative Neutrophil-Lymphocyte Ratio and Fibrinogen in Predicting Overall Survival of Patients with Glioblastoma Multiforme.
    Hao Y; Li X; Chen H; Huo H; Liu Z; Tian F; Chai E
    World Neurosurg; 2019 Aug; 128():e427-e433. PubMed ID: 31042598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative neutrophil-lymphocyte ratio correlated with glioma grading and glioblastoma survival.
    Weng W; Chen X; Gong S; Guo L; Zhang X
    Neurol Res; 2018 Nov; 40(11):917-922. PubMed ID: 30074469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative Neutrophil/Lymphocyte Ratio Is an Independent Prognostic Biomarker in Patients with Low-Grade Gliomas.
    Tan Z; Shen L; Wu H; Deng L; Li Z; Huang X
    World Neurosurg; 2019 Dec; 132():e585-e590. PubMed ID: 31442642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Prognostic Value of the Pretreatment Neutrophil/Lymphocyte Ratio in Patients with Glioblastoma Multiforme Brain Tumors: A Retrospective Cohort Study of Patients Treated with Combined Modality Surgery, Radiation Therapy, and Temozolomide Chemotherapy.
    Brenner A; Friger M; Geffen DB; Kaisman-Elbaz T; Lavrenkov K
    Oncology; 2019; 97(5):255-263. PubMed ID: 31288238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of inflammation markers in postoperative gliomas with or without adjuvant treatments.
    Luo Y; Deng R; Zhong Q; Luo D; Li X; Chen X; Tao S; Feng Z; Jiayi L; Huang Y; Li J; Liu W
    Medicine (Baltimore); 2021 Jun; 100(25):e26437. PubMed ID: 34160435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment neutrophil-to-lymphocyte/monocyte-to-lymphocyte ratio as prognostic biomarkers in glioma patients.
    Chim ST; Sanfilippo P; O'Brien TJ; Drummond KJ; Monif M
    J Neuroimmunol; 2021 Dec; 361():577754. PubMed ID: 34700046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of neutrophil-to-lymphocyte ratio in gliomas: a systematic review and meta-analysis.
    Lei YY; Li YT; Hu QL; Wang J; Sui AX
    World J Surg Oncol; 2019 Aug; 17(1):152. PubMed ID: 31472673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated preoperative neutrophil-to-lymphocyte ratio as a predictor of worse survival after resection in patients with brain metastasis.
    Mitsuya K; Nakasu Y; Kurakane T; Hayashi N; Harada H; Nozaki K
    J Neurosurg; 2017 Aug; 127(2):433-437. PubMed ID: 27911233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Threshold of the extent of resection for WHO Grade III gliomas: retrospective volumetric analysis of 122 cases using intraoperative MRI.
    Fujii Y; Muragaki Y; Maruyama T; Nitta M; Saito T; Ikuta S; Iseki H; Hongo K; Kawamata T
    J Neurosurg; 2018 Jul; 129(1):1-9. PubMed ID: 28885120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative Hematologic Inflammatory Markers as Prognostic Factors in Patients with Glioma.
    Bao Y; Yang M; Jin C; Hou S; Shi B; Shi J; Lin N
    World Neurosurg; 2018 Nov; 119():e710-e716. PubMed ID: 30092479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Prognostic Value of Preoperative Inflammatory Markers for Pathological Grading of Glioma Patients.
    Li B; Gao B; Zhu HJ; Luwor RB; Lu J; Zhang L; Kong B
    Technol Cancer Res Treat; 2024; 23():15330338241273160. PubMed ID: 39099463
    [No Abstract]   [Full Text] [Related]  

  • 13. Neutrophil-lymphocyte ratio dynamics during concurrent chemo-radiotherapy for glioblastoma is an independent predictor for overall survival.
    Mason M; Maurice C; McNamara MG; Tieu MT; Lwin Z; Millar BA; Menard C; Laperriere N; Milosevic M; Atenafu EG; Mason W; Chung C
    J Neurooncol; 2017 May; 132(3):463-471. PubMed ID: 28332000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corpus callosum involvement and postoperative outcomes of patients with gliomas.
    Chen KT; Wu TW; Chuang CC; Hsu YH; Hsu PW; Huang YC; Lin TK; Chang CN; Lee ST; Wu CT; Tseng CK; Wang CC; Pai PC; Wei KC; Chen PY
    J Neurooncol; 2015 Sep; 124(2):207-14. PubMed ID: 26033546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Prognosis of Neuroglioma Based on Dynamic Magnetic Resonance Enhancement.
    Li F; Zhang Y; Wang N; Song C; Gao Y; Diao X; Zhang H
    World Neurosurg; 2020 Jun; 138():663-671. PubMed ID: 31981784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of preoperative neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with glioma.
    Wang J; Xiao W; Chen W; Hu Y
    EXCLI J; 2018; 17():505-512. PubMed ID: 30034313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Survival of newly diagnosed malignant glioma patients on combined modality therapy].
    Yang QY; Shen D; Sai K; Jiang XB; Ke C; Zhang XH; Mou YG; Chen ZP
    Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(1):8-10. PubMed ID: 23578444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Significance of Preoperative Neutrophil-to-Lymphocyte Ratio in Surgically Resectable Pancreatic Neuroendocrine Tumors.
    Zhou B; Zhan C; Wu J; Liu J; Zhou J; Zheng S
    Med Sci Monit; 2017 Nov; 23():5574-5588. PubMed ID: 29168979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neutrophil to lymphocyte ratio in peripheral blood: a novel independent prognostic factor in patients with head and neck squamous cell carcinoma].
    Wu F; Wu LL; Zhu LX
    Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):29-32. PubMed ID: 28104030
    [No Abstract]   [Full Text] [Related]  

  • 20. Determining a cut-off residual tumor volume threshold for patients with newly diagnosed glioblastoma treated with temozolomide chemoradiotherapy: A multicenter cohort study.
    Woo PYM; Ho JMK; Tse TPK; Lam SW; Mak CHK; Chan DTM; Lee MWY; Wong ST; Chan KY; Poon WS
    J Clin Neurosci; 2019 May; 63():134-141. PubMed ID: 30712777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.